A new method for evaluating drug efficacy at the gene expression level.

Area of Science:

• Pharmacology
• Genomics
• Toxicology

Background:

• Natural medicines often exhibit multitarget effects, challenging traditional efficacy evaluation methods.
• Standard drug efficacy assessments may not fully capture the complex actions of natural products.

Purpose of the Study:

• To develop and validate a novel method for evaluating drug efficacy at the gene expression level.
• To assess the efficacy of natural hepatoprotective agents using this new gene expression-based approach.

Main Methods:

• Establishment of a rat liver injury model using carbon tetrachloride.
• Gene expression profiling via microarray technology in liver cells.
• Comparative efficacy assessment of curcumin and puerarin against a positive control (reduced glutathione).

Main Results:

• Hepatoprotective drug treatments significantly reduced the number of differentially expressed genes in liver tissue.
• The efficacy ranking based on gene expression analysis was curcumin > positive control drug > puerarin.
• Liver function indices and pathological findings corroborated the gene expression-based efficacy evaluation.

Conclusions:

• Drug efficacy can be effectively evaluated and ranked using gene expression profiling.
• This gene expression-based method provides a comprehensive approach to understanding natural product efficacy.
• The study highlights curcumin as a potent hepatoprotective agent based on multitarget gene expression modulation.